Showing results (51-60 of 122) with videos related to
Sort By:
Pageof 13
Oncology Letters|February 14, 2018
<i>LATS2</i> promoter hypermethylation and its effect on gene expression in human breast cancerSaki Matsui, Naofumi Kagara, Chieko Mishima, et al.Breast Cancer Research : BCR|August 8, 2019
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancerAmi Hori, Masafumi Shimoda, Yasuto Naoi, et al.Breast Cancer Research and Treatment|May 6, 2018
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patientsRyo Tsunashima, Yasuto Naoi, Kenzo Shimazu, et al.Breast Cancer Research and Treatment|June 28, 2011
MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamideMasatsugu Okishiro, Seung Jin Kim, Ryo Tsunashima, et al.Journal of Surgical Case Reports|September 22, 2025
Isolated splenic metastasis presenting at diagnosis of HER2-positive <i>de novo</i> metastatic breast cancer: a case reportMaika Yoshioka, Masafumi Shimoda, Kaori Abe, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[A Case Study of Severe Myelosuppression Induced by Adjuvant Chemotherapy in a Breast Cancer Patient with Concurrent Immune Thrombocytopenia(ITP)]Mayuko Kamano, Nanae Masunaga, Ryu Tokui, et al.Medical Oncology (Northwood, London, England)|May 8, 2019
Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancerKenzo Shimazu, Tomonori Tanei, Yasuhiro Tamaki, et al.Breast Cancer Research and Treatment|October 27, 2018
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancerAko Matsushita Ohara, Yasuto Naoi, Kenzo Shimazu, et al.Oncology Letters|April 19, 2024
Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancerMasafumi Shimoda, Yasufumi Sato, Kaori Abe, et al.Anticancer Research|November 29, 2025
Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast CancerTakeshi Usui, Masafumi Shimoda, Kaori Abe, et al.Pageof 13